Skip to content
10-Q

Quarterly Report

BIOQUEST CORP. BQST

0001493152-22-025605

← back to feed
Filed
Sep 12, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Jul 31, 2022 11.49B sh
Operating Cash Flow Q1 2023 · Jul 31, 2022 −$18.59K
Operating Cash Flow Q1 2023 · Jul 31, 2021 −$62.52K
Cash And Equivalents Q1 2023 · Jul 31, 2022 $14.96K
Cash And Equivalents Q1 2023 · Apr 30, 2022 $33.54K
Stockholders Equity Q1 2023 · Jul 31, 2022 −$536.42K
Stockholders Equity Q1 2023 · Apr 30, 2022 −$432.99K
Stockholders Equity Q1 2023 · Jul 31, 2021 −$2.14M
Stockholders Equity Q1 2023 · Apr 30, 2021 −$1.77M
Current Liabilities Q1 2023 · Jul 31, 2022 $551.37K
Current Liabilities Q1 2023 · Apr 30, 2022 $466.53K
Total Liabilities Q1 2023 · Jul 31, 2022 $551.37K
Total Liabilities Q1 2023 · Apr 30, 2022 $466.53K
Current Assets Q1 2023 · Jul 31, 2022 $14.96K
Current Assets Q1 2023 · Apr 30, 2022 $33.54K
Total Assets Q1 2023 · Jul 31, 2022 $14.96K
Total Assets Q1 2023 · Apr 30, 2022 $33.54K
Eps Basic Q1 2023 · Jul 31, 2022 −$0.01
Eps Basic Q1 2023 · Jul 31, 2021 −$0.05
Net Income Q1 2023 · Jul 31, 2022 −$123.43K
Net Income Q1 2023 · Jul 31, 2021 −$437.05K
Operating Income Q1 2023 · Jul 31, 2022 −$49.67K
Operating Income Q1 2023 · Jul 31, 2021 −$464.15K
Stock Issued Q1 2023 · Jul 14, 2022 40K sh
Stock Issued Q1 2023 · Jun 23, 2022 90M sh